Abstract
Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S177-S191 |
| Journal | Dermatologic Surgery |
| Volume | 42 |
| DOIs | |
| State | Published - May 15 2016 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
- Surgery
Cite this
AComprehensive approach to multimodal facial aesthetic treatment : Injection techniques and treatment characteristics from the HARMONY study. / Narurkar, Vic A.; Cohen, Joel L.; Dayan, Steven; Kaminer, Michael S.; Rivkin, Alexander; Shamban, Ava; Sykes, Jonathan M; Teller, Craig F.; Weinkle, Susan H.; Philip Werschler, W.; Drinkwater, Adrienne; Pucci, Michael L.; Gallagher, Conor J.
In: Dermatologic Surgery, Vol. 42, 15.05.2016, p. S177-S191.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - AComprehensive approach to multimodal facial aesthetic treatment
T2 - Injection techniques and treatment characteristics from the HARMONY study
AU - Narurkar, Vic A.
AU - Cohen, Joel L.
AU - Dayan, Steven
AU - Kaminer, Michael S.
AU - Rivkin, Alexander
AU - Shamban, Ava
AU - Sykes, Jonathan M
AU - Teller, Craig F.
AU - Weinkle, Susan H.
AU - Philip Werschler, W.
AU - Drinkwater, Adrienne
AU - Pucci, Michael L.
AU - Gallagher, Conor J.
PY - 2016/5/15
Y1 - 2016/5/15
N2 - Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.
AB - Background The Harmony study is the first clinical trial to assess the impact of a global approach to facial rejuvenation with several minimally invasive modalities, using patient-reported outcome measures. OBJECTIVE Provide details of this treatment approach and describe investigators' experiences and recommendations based on this study. METHODS This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juv éderm Voluma XC), HYC-24L (Juv éderm Ultra XC), HYC-24L+ (Juv éderm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% ophthalmic solution (Latisse). Treatment-naive adults with moderate-to-severe facial lines and folds and eyelash hypotrichosis received onlabel, staged treatment with fillers. Bimatoprost was self-administered once daily for 17 weeks from day 1. OnabotulinumtoxinA was administered for glabellar lines, crow's feet lines, or both at month 3. RESULTS Overall, 100 subjects received bimatoprost for eyelash hypotrichosis, 96 received onabotulinumtoxinA for glabellar lines and/or crow's feet lines, and 96 received VYC-20L for midface volume deficit. From 17 to 96 subjects received HYC-24L and/or HYC-24L+ for nasolabial folds, oral commissures, marionette lines, perioral lines, or radial cheek lines. Injections of filler generally progressed from cranial to caudal, with midface injected first. Investigator-reported factors that may have contributed to the potential benefits of this approach include the critical role of themidface in facial aesthetics, use of lower volumes of filler in individual facial areas, and anesthetic effects. CONCLUSION The investigators' perspectives and experience with the injection pattern, sequencing, volumes, and techniques may provide valuable guidance for a multimodal approach to facial aesthetic treatment.
UR - http://www.scopus.com/inward/record.url?scp=84969509089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969509089&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000000743
DO - 10.1097/DSS.0000000000000743
M3 - Article
C2 - 27128246
AN - SCOPUS:84969509089
VL - 42
SP - S177-S191
JO - Dermatologic Surgery
JF - Dermatologic Surgery
SN - 1076-0512
ER -